Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × neratinib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neoplasms 1 Meningioma 1 Malignant Female Reproductive System Neoplasm 1 Inflammatory Breast Neoplasms 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1 Ependymoma 1 Endometrial Neoplasms 1

Interventions

pembrolizumab 19 Cisplatin 9 Carboplatin 8 Bevacizumab 8 Specimen Handling 7 Radiotherapy 7 Human Papillomavirus DNA Tests 7 Colposcopy 7 Paclitaxel 6 Magnetic Resonance Spectroscopy 5 Gemcitabine 5 Biopsy 5 lenvatinib 4 Fulvestrant 4 Drug Therapy 4 zimberelimab 3 toripalimab 3 tisotumab vedotin 3 dostarlimab 3 atezolizumab 3 Topotecan 3 Restraint, Physical 3 Radiotherapy, Intensity-Modulated 3 Pemetrexed 3 Nivolumab 3 Mass Screening 3 Cyclophosphamide 3 Brachytherapy 3 spartalizumab 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡